Breast cancer survivor offers wisdom at Faulkner satellite center
Call 877-422-3324 today to make an appointment
Make your appointment or second opinion with Dana-Farber today to meet with an onsite specialist.
Can’t get to Boston? Explore our Online Second Opinion service to get expert advice from Dana-Farber oncologists.
Toll-Free Number866-408-DFCI (3324)
Discover the ways to give and how to get involved to support Dana-Farber.
Poet Richard Fox gains insight – and material – through cancer treatment
A family faces cancer in an unfamiliar city – with help
Choosing mastectomy or not: Studying young women's surgical choices
Jeff's targeted therapy has kept his advanced lung cancer at bay.
Dana-Farber Cancer Institute has earned Magnet® status from the American Nurses Credentialing Center (ANCC) for the third time. This prestigious designation recognizes excellence in nursing and health care delivery and has been given to 7 percent of hospitals worldwide. In 2005, Dana-Farber became the first cancer center in New England to receive Magnet status.
"The ANCC Magnet credential recognizes excellence in nursing care delivery, innovation and evidenced-based practice. It highlights the exquisite nature of our interdisciplinary practice model and demonstrates, through quality, workforce and organizational outcomes, that our practice is outstanding, while constantly striving for improvement," says Patricia Reid Ponte, RN, DNSc, FAAN, NEA-BC, Dana-Farber's senior vice president for patient care services and chief nursing officer. "It is an honor for me to be working alongside such extraordinary nurses."
Evidence shows that hospitals that are Magnet-recognized are among the most positive, professional practice environments where nurses collaborate effectively with physicians, demonstrate innovative nursing practice, and provide patient-centered care, according to the ANCC. Additionally, patient and staff satisfaction is higher at Magnet hospitals.
"This distinction exemplifies Dana-Farber's continuing commitment to providing the highest quality care and clinical trials to our patients and families," says Dana-Farber President and Chief Executive Officer Edward J. Benz, Jr., MD.